Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract von Mach, François, Ray, Kausik K, Wiklund, Olov, Corsini, Alberto, Catapano, Alberico L, Bruckert, Eric, De Backer, Guy, Hegele, Robert A, Hovingh, G Kees, Jacobson, Terry A, Krauss, Ronald M, Laufs, Ulrich, Leiter, Lawrence A, März, Winfried, Nordestgaard, Børge G, Raal, Frederick J, Roden, Michael, Santos, Raul D, Stein, Evan A, Stroes, Erik S, Thompson, Paul D, Tokgözoğlu, Lale, Vladutiu, Georgirene D, Gencer, Baris, Stock, Jane K, Ginsberg, Henry N, Chapman, M John

Volltext

GATM Polymorphism Associated with the Risk for Statin-Induced Myopathy Does Not Replicate in Case-Control Analysis of 715 Dyslipidemic Individuals von Luzum, Jasmine A., Kitzmiller, Joseph P., Isackson, Paul J., Ma, Changxing, Medina, Marisa W., Dauki, Anees M., Mikulik, Eduard B., Ochs-Balcom, Heather M., Vladutiu, Georgirene D.

Volltext

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management von Stroes, Erik S, Thompson, Paul D, Corsini, Alberto, Vladutiu, Georgirene D, Raal, Frederick J, Ray, Kausik K, Roden, Michael, Stein, Evan, Tokgözoğlu, Lale, Nordestgaard, Børge G, Bruckert, Eric, De Backer, Guy, Krauss, Ronald M, Laufs, Ulrich, Santos, Raul D, Hegele, Robert A, Hovingh, G Kees, Leiter, Lawrence A, Mach, Francois, März, Winfried, Newman, Connie B, Wiklund, Olov, Jacobson, Terry A, Catapano, Alberico L, Chapman, M John, Ginsberg, Henry N

Volltext

Genetic predisposition to statin myopathy von Vladutiu, Georgirene D

Volltext

Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency von Isackson, Paul J., Bennett, Michael J., Vladutiu, Georgirene D.

Volltext

CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency von Isackson, Paul J., Bennett, Michael J., Lichter-Konecki, Uta, Willis, Mary, Nyhan, William L., Sutton, V. Reid, Tein, Ingrid, Vladutiu, Georgirene D.

Volltext

Ryanodine Receptor Type 1 Gene Variants in the Malignant Hyperthermia-Susceptible Population of the United States von Brandom, Barbara W., Bina, Saiid, Wong, Cynthia A., Wallace, Tarina, Visoiu, Mihaela, Isackson, Paul J., Vladutiu, Georgirene D., Sambuughin, Nyamkhishig, Muldoon, Sheila M.

Volltext

RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms von Isackson, Paul J, Wang, Jianxin, Zia, Mohammad, Spurgeon, Paul, Levesque, Adrian, Bard, Jonathan, James, Smitha, Nowak, Norma, Lee, Tae Keun, Vladutiu, Georgirene D

Volltext

Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease von Scaglia, Fernando, Towbin, Jeffrey A, Craigen, William J, Belmont, John W, Smith, E. O'Brian, Neish, Stephen R, Ware, Stephanie M, Hunter, Jill V, Fernbach, Susan D, Vladutiu, Georgirene D, Wong, Lee-Jun C, Vogel, Hannes

Volltext

Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms von Chen, Wilson, Ochs-Balcom, Heather M, Ma, Changxing, Isackson, Paul J, Vladutiu, Georgirene D, Luzum, Jasmine A

Volltext

Clinical features related to statin‐associated muscle symptoms von Ochs‐Balcom, Heather M., Nguyen, Ly Minh, Ma, Changxing, Isackson, Paul J., Luzum, Jasmine A., Kitzmiller, Joseph P., Tarnopolsky, Mark, Weisman, Michael, Christopher‐Stine, Lisa, Peltier, Wendy, Wortmann, Robert L., Vladutiu, Georgirene D.

Volltext

Genetic risk factors associated with lipid-lowering drug-induced myopathies von Vladutiu, Georgirene D., Simmons, Zachary, Isackson, Paul J., Tarnopolsky, Mark, Peltier, Wendy L., Barboi, Alexandru C., Sripathi, Naganand, Wortmann, Robert L., Phillips, Paul S.

Volltext

Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies von Vladutiu, Georgirene D., Isackson, Paul J., Kaufman, Kenneth, Harley, John B., Cobb, Beth, Christopher-Stine, Lisa, Wortmann, Robert L.

Volltext

SIMD commentary on FDA oversight of laboratory-developed testing von Vladutiu, Georgirene D.

Volltext

Mitochondrial diseases in North America: An analysis of the NAMDC Registry von Barca, Emanuele, Long, Yuelin, Cooley, Victoria, Schoenaker, Robert, Emmanuele, Valentina, DiMauro, Salvatore, Cohen, Bruce H., Karaa, Amel, Vladutiu, Georgirene D., Haas, Richard, Van Hove, Johan L.K., Scaglia, Fernando, Parikh, Sumit, Bedoyan, Jirair K., DeBrosse, Susanne D., Gavrilova, Ralitza H., Saneto, Russell P., Enns, Gregory M., Stacpoole, Peter W., Ganesh, Jaya, Larson, Austin, Zolkipli-Cunningham, Zarazuela, Falk, Marni J., Goldstein, Amy C., Tarnopolsky, Mark, Gropman, Andrea, Camp, Kathryn, Krotoski, Danuta, Engelstad, Kristin, Rosales, Xiomara Q., Kriger, Joshua, Grier, Johnston, Buchsbaum, Richard, Thompson, John L.P., Hirano, Michio

Volltext

The 2010 Donough O'Brien Presidential Address: The contribution of heterozygosity to disease von Vladutiu, Georgirene D.

Volltext

Malignant Hyperthermia-Like Syndrome and Carnitine Palmitoyltransferase II Deficiency with Heterozygous R503C Mutation von Hogan, Kirk J., Vladutiu, Georgirene D.

Volltext

SLCO1B1 Variants and Statin-Induced Myopathy von Vladutiu, Georgirene D, Isackson, Paul J

Volltext

Novel mutations in the gene encoding very long-chain acyl-CoA dehydrogenase identified in patients with partial carnitine palmitoyltransferase ii deficiency von Isackson, Paul J., Sutton, Kristin A., Hostetler, Karl Y., Vladutiu, Georgirene D.

Volltext

The FDA announces new drug labeling for pharmacogenetic testing: Is personalized medicine becoming a reality? von Vladutiu, Georgirene D.

Volltext